Mechanisms of Protein Oligomerization: Inhibitor of Functional Amyloids Templates α-Synuclein Fibrillation
Open Access
- 9 February 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 134 (7), 3439-3444
- https://doi.org/10.1021/ja209829m
Abstract
Small organic molecules that inhibit functional bacterial amyloid fibers, curli, are promising new antibiotics. Here we investigated the mechanism by which the ring-fused 2-pyridone FN075 inhibits fibrillation of the curli protein CsgA. Using a variety of biophysical techniques, we found that FN075 promotes CsgA to form off-pathway, non-amyloidogenic oligomeric species. In light of the generic properties of amyloids, we tested whether FN075 would also affect the fibrillation reaction of human α-synuclein, an amyloid-forming protein involved in Parkinson’s disease. Surprisingly, FN075 stimulates α-synuclein amyloid fiber formation as measured by thioflavin T emission, electron microscopy (EM), and atomic force microscopy (AFM). NMR data on 15N-labeled α-synuclein show that upon FN075 addition, α-synuclein oligomers with 7 nm radius form in which the C-terminal 40 residues remain disordered and solvent exposed. The polypeptides in these oligomers contain β-like secondary structure, and the oligomers are detectable by AFM, EM, and size-exclusion chromatography (SEC). Taken together, FN075 triggers oligomer formation of both proteins: in the case of CsgA, the oligomers do not proceed to fibers, whereas for α-synuclein, the oligomers are poised to rapidly form fibers. We conclude that there is a fine balance between small-molecule inhibition and templation that depends on protein chemistry.Funding Information
- National Institutes of Health
- Swedish Research Council Formas
This publication has 33 references indexed in Scilit:
- In vivo demonstration that α-synuclein oligomers are toxicProceedings of the National Academy of Sciences of the United States of America, 2011
- Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillationProceedings of the National Academy of Sciences of the United States of America, 2011
- Seeded Aggregation and Toxicity of α-Synuclein and Tau: CELLULAR MODELS OF NEURODEGENERATIVE DISEASESJournal of Biological Chemistry, 2010
- Accelerated formation of α-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutationsJournal of Bioenergetics and Biomembranes, 2010
- Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formationNature Chemical Biology, 2009
- Effect of Pseudorepeat Rearrangement on α-Synuclein Misfolding, Vesicle Binding, and Micelle BindingJournal of Molecular Biology, 2009
- Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid BaicaleinJournal of Molecular Biology, 2008
- The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerizationProceedings of the National Academy of Sciences of the United States of America, 2007
- Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteriaProceedings of the National Academy of Sciences of the United States of America, 2006
- Conformational properties of α-synuclein in its free and lipid-associated statesJournal of Molecular Biology, 2001